Sarah T. Connolly’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Sarah T. Connolly’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-53,001	Closed	-$335K	–	95
2022 Q4	$335K	Hold	53,001	–	–	0.23%	82
2022 Q3	$271K	Hold	53,001	–	–	0.2%	88
2022 Q2	$332K	Hold	53,001	–	–	0.23%	81
2022 Q1	$188K	Hold	53,001	–	–	0.11%	93
2021 Q4	$266K	Hold	53,001	–	–	0.15%	88
2021 Q3	$388K	Hold	53,001	–	–	0.32%	77
2021 Q2	$455K	Hold	53,001	–	–	0.37%	72
2021 Q1	$574K	Hold	53,001	–	–	0.51%	61
2020 Q4	$523K	Buy	+53,001	New	+$347K	0.48%	61

Sarah T. Connolly's FSTX Position: Q1 2023 in Review

Sarah T. Connolly sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 53,001 shares — an estimated $335K sold.

Sarah T. Connolly first reported a position in FSTX in Q4 2020 and held it in 9 quarters. The position peaked at $574K in Q1 2021. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Sarah T. Connolly reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Sarah T. Connolly sold 53,001 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $335K.
Sarah T. Connolly first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
Sarah T. Connolly's F-star Therapeutics, Inc. Common Stock position peaked at $574K in Q1 2021.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Sarah T. Connolly's 13F filing for Q1 2023, filed 12 May 2023.